Evidence map›Paper›PMID 35539048›Full record

ArticleRSC advances2019

A novel drug-drug nanohybrid for the self-delivery of porphyrin and

Changfu Shan, Jiaxi Ru, Meina Zhang, Jing Cao, Weisheng Liu, Huichen Guo, Yu Tang

Abstract read
In one paragraph

Article in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Changfu ShanState Key Laboratory of Applied Organic Chemistry, Key Laboratory of Nonferrous Metal Chemistry and Resources Utilization of Gansu Province, College of Chemistry and Chemical Engineering, Lanzhou University Lanzhou 730000 P. R. China tangyu@lzu.edu.cn caoj@lzu.edu.cn.
Jiaxi RuState Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences Lanzhou 730046 P. R. China guohuichen@caas.cn.ORCID https://orcid.org/0000-0002-7469-1911
Meina ZhangState Key Laboratory of Applied Organic Chemistry, Key Laboratory of Nonferrous Metal Chemistry and Resources Utilization of Gansu Province, College of Chemistry and Chemical Engineering, Lanzhou University Lanzhou 730000 P. R. China tangyu@lzu.edu.cn caoj@lzu.edu.cn.
Jing CaoState Key Laboratory of Applied Organic Chemistry, Key Laboratory of Nonferrous Metal Chemistry and Resources Utilization of Gansu Province, College of Chemistry and Chemical Engineering, Lanzhou University Lanzhou 730000 P. R. China tangyu@lzu.edu.cn caoj@lzu.edu.cn.ORCID https://orcid.org/0000-0003-3978-911X
Weisheng LiuState Key Laboratory of Applied Organic Chemistry, Key Laboratory of Nonferrous Metal Chemistry and Resources Utilization of Gansu Province, College of Chemistry and Chemical Engineering, Lanzhou University Lanzhou 730000 P. R. China tangyu@lzu.edu.cn caoj@lzu.edu.cn.ORCID https://orcid.org/0000-0001-5448-6315
Huichen GuoState Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences Lanzhou 730046 P. R. China guohuichen@caas.cn.
Yu TangState Key Laboratory of Applied Organic Chemistry, Key Laboratory of Nonferrous Metal Chemistry and Resources Utilization of Gansu Province, College of Chemistry and Chemical Engineering, Lanzhou University Lanzhou 730000 P. R. China tangyu@lzu.edu.cn caoj@lzu.edu.cn.ORCID https://orcid.org/0000-0003-3933-043X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The thriving development of nanotechnology has greatly promoted the development of drug delivery systems (DDSs) in the past decades. However, most DDSs themselves cannot serve as diagnostic reagents and must be metabolized, by which they may become poisonous and even cause immune reactions. In this study, a novel self-delivery drug-drug system (SDDS) nanohybrid based on the coordination assembly of a photodynamic reagent, tetra-(4-carboxyphenyl)porphyrin (TCPP), and a chemotherapy reagent,

Identifiers

PMID35539048
PMCPMC9075146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.